Page 61 - Read Online

Page 36 of 38 J Cancer Metastasis Treat 2020;6:5 I http://dx.doi.org/10.20517/2394-4722.2020.13

parasitic infections in the United States based on our own patient history and testing. The conceptual
thesis and practical observations of extensive damage of parasites to human tissues and the initiation of
host defense strategies causing out of control cell divisions leading to metastasis is emphasized. A brief
introduction to laboratory procedures, misdiagnoses/mistreatment, and impact on public health, especially
cancer, is made. A systematic treatment of protozoan and helminth (worm) parasites follows, emphasizing
epidemiology and exposure, symptoms, and gross pathology. Herbal and allopathic remedies including
our own anti-parasitic herbal product Freedom/Cleanse/Restore are presented. All topics are illustrated
with labeled pictures of the various kinds of parasites and their gross pathology in human tissues, when
applicable. The presentation is followed by a brief discussion of case histories and treatment of intestinal
pathogenic bacteria that usually cause GI symptoms similar to those caused by intestinal parasites.

50. Role of biobanks in cancer research

Judita Kinkorova

University Hospital in Pilsen and Charles University, Faculty of Medicine in Pilsen, Pilsen 304 60, Czech
Republic.

Background and aim: Biobanks are an important tool for biomedical research and a pillar of personalized
medicine. Biobanks are collections of biological material and the associated data and information stored in
[1]
an organized system, for a population or a large subset of population (OECD definition) . During last three
decades, the role of biobanks has increased dramatically. They act as sources for a wide range of biomedical
research and support the basic principles of personalized medicine. They contribute to prevention, early
[2]
diagnosis, prognosis, right treatment, therapy monitoring, and optimal approach to a patient . Cancer
was and remains as one of the main causes of mortality and morbidity worldwide. The number of cancers,
especially rare cancers, make cancer diseases serious candidates for personalized medicine approaches.

How can biobanks contribute to the process of cancer treatment?

Biobanks as sources of various human biological material from different patients, from different regions,
males and females, young and elderly, with other comorbidities, before and after surgery, different social
and environmental associations, different ethnic groups, etc., offer a wide range of samples for any type of
research. Based on these characteristics, biobanks are a cornerstone for the discovery of new biomarkers,
[3]
drugs, techniques, applications, and innovations . On the other hand, data and information connected
with samples are another source for modeling, data applications, and artificial intelligence applications,
with respect to ethical, legal, and social issues. Personalized medicine principles guarantee the best possible
approach to every patient, which means prevention, early diagnosis, treatment, and treatment monitoring.
Biobanking is a phenomenon that is intrinsically based on international collaboration, including samples,
data, and information exchange, as no one institution can cover all the challenges all over the world by
offering biobanking. Biobanking requires a multidisciplinary international strategy.

Conclusion: Biobanks are efficient tools for new biomedical research and a personalized medicine approach
to every patient and contribute to support healthcare systems, international collaboration, biomedical
research, and innovation.

REFERENCES
1. Kinkorová J. Biobanks in the era of personalized medicine: objectives, challenges, and innovation: Overview. EPMA J 2016;7:4.
2. Kinkorová J. The 39th annual conference: Immunoanalytical Days - Pilsen, Czech Republic, 11-13 March 2018. Biomark Med
2019;13:601-4.
3. Kinkorová J, Topolčan O. Biobanks in Horizon 2020: sustainability and attractive perspectives. EPMA J 2018;9:345-53.